<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2020-276-280</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2893</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Минеральная плотность кости и состояние сосудистой стенки в зависимости от биохимических маркеров воспаления у женщин в постменопаузе</article-title><trans-title-group xml:lang="en"><trans-title>RELATIONSHIP OF BONE MINERAL DENSITY AND VASCULAR WALL CONDITION WITH BIOCHEMICAL MARKERS OF INFLAMMATION IN POSTMENOPAUSAL WOMEN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1763-0725</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скрипникова</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Skripnikova</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ирина Анатольевна Скрипникова </p></bio><bio xml:lang="en"><p>Irina Skripnikova </p></bio><email xlink:type="simple">ISkripnikova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7426-7179</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алиханова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Alikhanova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>101000, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8164-8946</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колчина</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolchina</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>101000, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7036-4756</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косматова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosmatova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>101000, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0364-0831</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новиков</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>101000, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0615-4548</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Выгодин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vygodin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>101000, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>101000, Москва, Петроверигский пер., 10</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр терапии и профилактической медицины» Минздрава России<country>Россия</country></aff><aff xml:lang="en">National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>24</day><month>06</month><year>2020</year></pub-date><volume>58</volume><issue>3</issue><fpage>276</fpage><lpage>280</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Скрипникова И.А., Алиханова Н.А., Колчина М.А., Косматова О.В., Новиков В.Е., Выгодин В.А., Драпкина О.М., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Скрипникова И.А., Алиханова Н.А., Колчина М.А., Косматова О.В., Новиков В.Е., Выгодин В.А., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Skripnikova I.A., Alikhanova N.A., Kolchina M.A., Kosmatova O.V., Novikov V.E., Vygodin V.A., Drapkina O.M.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2893">https://rsp.mediar-press.net/rsp/article/view/2893</self-uri><abstract><p>Цель исследования – изучить корреляцию костной массы, параметров сосудистой жесткости и субклинического атеросклероза с биохимическими маркерами воспаления у женщин в постменопаузе. Материал и методы. В одномоментное исследование включены 98 пациенток в возрасте 45–82 лет, наблюдавшихся амбулаторно и подписавших информированное согласие. В исследование не включали пациенток с любыми клиническими проявлениями атеросклероза, злокачественными новообразованиями, с заболеваниями, вызывающими вторичный остеопороз, наличием симптомов острых бактериальных или вирусных инфекций и обострения хронических болезней, принимающих препараты, влияющие на костный обмен и на показатели сосудистой жесткости. Уровень С-реактивного белка (СРБ) определяли высокочувствительным иммунотурбидиметрическим методом с применением карбоксилированных полистироловых частиц. Концентрацию интерлейкина 6 (ИЛ6) измеряли с помощью иммуноферментного анализа. Толщина комплекса интима–медиа (КИМ), наличие и количество атеросклеротических бляшек (АБ) исследовались с помощью дуплексного сканирования. Скорость распространения пульсовой волны (СРПВ), индекс аугментации (ИА) измеряли методом аппланационной тонометрии (SphygmoCor, AtCor Medical Pty. Ltd., Австралия). Минеральную плотность кости (МПК) позвоночника и проксимального отдела бедра измеряли с помощью двухэнергетической рентгеновской абсорбциометрии. Результаты и обсуждение. Отмечены повышение параметров сосудистой ригидности, субклинического атеросклероза, уровня СРБ и снижение костной массы с увеличением продолжительности менопаузы. Показатели сосудистой жесткости, включая толщину КИМ (r=0,26; p&lt;0,05), ИА (r=0,25; p&lt;0,05), наличие АБ (r=0,24; p&lt;0,05), СРПВ (r=0,23; p&lt;0,05), прямо коррелируют с уровнем СРБ. А между МПК LI–IV и СРБ обнаружена отрицательная корреляция (r=-0,31; p&lt;0,05). Вероятность обнаружения утолщения КИМ при высоком уровне СРБ увеличивалась в 2,64 раза, АБ – в 3,18 раза, а низкой МПК – в 2,4 раза. Ассоциации костной массы, показателей субклинического атеросклероза и сосудистой жесткости с ИЛ6 не выявлено. Заключение. Снижение костной массы и развитие остеопороза у женщин в постменопаузе ассоциировались с повышением сосудистой жесткости и наличием признаков субклинического атеросклероза, а также с высоким уровнем СРБ, что позволяет обсуждать общие механизмы развития остеопороза и атеросклероза, а также участие в них процессов хронического воспаления.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to investigate the correlation of bone mass, the parameters of vascular stiffness and subclinical atherosclerosis with biochemical markers of inflammation in postmenopausal women. Subjects and methods. The cross-sectional investigation included 98 patients aged 45–82 years who were followed up in the outpatient setting and signed an informed consent. The investigation did not include patients with any clinical manifestations of atherosclerosis, malignant neoplasms, with diseases causing secondary osteoporosis, as well as with the presence of symptoms of acute bacterial or viral infections and an exacerbation of chronic diseases, who took drugs affecting bone metabolism and vascular stiffness. C-reactive protein (CRP) level was determined by a high-sensitive immunoturbidimetric assay using carboxylated polystyrene particles. interleukin (IL)-6 concentration was measured by an enzyme immunoassay. The intima-media thickness (IMT), the presence and number of atherosclerotic plaques (ASP) were studied with duplex scanning. Pulse wave velocity (PWV) and augmentation index (AI) were measured by applanation tonometry using a SphygmoCor device (AtCor Medical Pty. Ltd., Sydney, Australia). Lumbar spine and hip bone mineral density (BMD) was determined using dual energy X-ray absorptiometry. Results and discussion. There was an increase in the parameters of vascular stiffness, subclinical atherosclerosis, and CRP level and a decrease in bone mass with a longer length of menopause. The vascular stiffness parameters, including IMT (r=0.26; p&lt;0.05), AI (r=0.25; p&lt;0.05), the presence of ASP (r=0.24; p&lt;0.05), and PWV (r=0.23; p&lt;0.05), directly correlated with CRP level. A negative correlation was found between LI–IV BMD and CRP (r=-0.31; p&lt;0.05). The probability of detecting increased IMT with a high CRP level was increased by 2.64 times, ASP by 3.18 times, and low BMD by 2.4 times. There was no association of bone mass, and the parameters of subclinical atherosclerosis and vascular stiffness with IL-6.  Conclusion. Lower bone mass and the development of osteoporosis in postmenopausal women were associated with increased vascular stiffness and the presence of signs of subclinical atherosclerosis, and with a high level of CRP, which allows one to discuss the common mechanisms for development of osteoporosis and atherosclerosis, as well as the involvement of chronic inflammation in them.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>минеральная плотность кости</kwd><kwd>С-реактивный белок</kwd><kwd>интерлейкин 6</kwd><kwd>скорость распространения пульсовой волны</kwd><kwd>индекс аугментации</kwd><kwd>комплекс интима–медиа</kwd><kwd>постменопауза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bone mineral density</kwd><kwd>C-reactive protein</kwd><kwd>interleukin-6</kwd><kwd>pulse wave velocity</kwd><kwd>augmentation index</kwd><kwd>intima-media complex</kwd><kwd>postmenopause</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Laroche M, Pecourneau V, Blain H, et al. Osteoporosis and ischemic cardiovascular disease. Joint Bone Spine. 2017;84(4):427-32. doi: 10.1016/j.jbspin.2016.09.022</mixed-citation><mixed-citation xml:lang="en">Laroche M, Pecourneau V, Blain H, et al. Osteoporosis and ischemic cardiovascular disease. Joint Bone Spine. 2017;84(4):427-32. doi: 10.1016/j.jbspin.2016.09.022</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Caffarelli C, Montagnani A, Nuti R, et al. Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies. Clin Interv Aging. 2017;30:1819-28. doi: 10.2147/CIA.S138002</mixed-citation><mixed-citation xml:lang="en">Caffarelli C, Montagnani A, Nuti R, et al. Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies. Clin Interv Aging. 2017;30:1819-28. doi: 10.2147/CIA.S138002</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Marcovitz PA, Tran HH, Franklin BA, et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol. 2005;96(8):1059-63. doi: 10.1016/j.amjcard.2005.06.034</mixed-citation><mixed-citation xml:lang="en">Marcovitz PA, Tran HH, Franklin BA, et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol. 2005;96(8):1059-63. doi: 10.1016/j.amjcard.2005.06.034</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hyder JA, Allison MA, Wong N, et al. Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal aortic Calcium Study. Am J Epidemiol. 2009;169:186- 94. doi: 10.1093/aje/kwn303</mixed-citation><mixed-citation xml:lang="en">Hyder JA, Allison MA, Wong N, et al. Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal aortic Calcium Study. Am J Epidemiol. 2009;169:186- 94. doi: 10.1093/aje/kwn303</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Скрипникова ИА, Алиханова НА, Ткачева ОН и др. Ассоциация параметров сосудистой жесткости и субклинического атеросклероза с костной массой у женщин в постменопаузе. Кардиоваскулярная терапия и профилактика. 2016;15(2):51-6. doi: 10.15829/1728-8800-2016-2-51-56 [Skripnikova IA, Alikhanovа NA, Tkacheva ON, et al. Association of vessel stiffness parameters and subclinical atherosclerosis and mass of bone tissue in postmenopausal women. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2016;15(2):51-6. doi: 10.15829/1728-8800-2016-2-51-56 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Скрипникова ИА, Алиханова НА, Ткачева ОН и др. Ассоциация параметров сосудистой жесткости и субклинического атеросклероза с костной массой у женщин в постменопаузе. Кардиоваскулярная терапия и профилактика. 2016;15(2):51-6. doi: 10.15829/1728-8800-2016-2-51-56 [Skripnikova IA, Alikhanovа NA, Tkacheva ON, et al. Association of vessel stiffness parameters and subclinical atherosclerosis and mass of bone tissue in postmenopausal women. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2016;15(2):51-6. doi: 10.15829/1728-8800-2016-2-51-56 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pestka S, Krause CD, Sarkar D, et al. IL-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929-79. doi: 10.1146 annurev.immunol 22.012703.104622</mixed-citation><mixed-citation xml:lang="en">Pestka S, Krause CD, Sarkar D, et al. IL-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929-79. doi: 10.1146 annurev.immunol 22.012703.104622</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ramos AM, Pellanda LC, Gus I, et al. Inflammatory markers of cardiovascular disease in the elderly. Arq Bras Cardiol. 2009 Mar;92(3):221-8. doi: 10.1590/s0066-782x2009000300012</mixed-citation><mixed-citation xml:lang="en">Ramos AM, Pellanda LC, Gus I, et al. Inflammatory markers of cardiovascular disease in the elderly. Arq Bras Cardiol. 2009 Mar;92(3):221-8. doi: 10.1590/s0066-782x2009000300012</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Clowes JA, Rigs BL, Khosla S. The role of immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005;208:207-27. doi: 10.1111/j.0105-2896.2005.00334.x</mixed-citation><mixed-citation xml:lang="en">Clowes JA, Rigs BL, Khosla S. The role of immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005;208:207-27. doi: 10.1111/j.0105-2896.2005.00334.x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pfeilschifter J, Kö ditz R, Pfohl M, et al. Changes in proinflammatory cytokine activity after menopause. Endocrine Rev. 2009;23:90- 119. doi: 10.1210/edrv.23.1.0456</mixed-citation><mixed-citation xml:lang="en">Pfeilschifter J, Kö ditz R, Pfohl M, et al. Changes in proinflammatory cytokine activity after menopause. Endocrine Rev. 2009;23:90- 119. doi: 10.1210/edrv.23.1.0456</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ding C, Paramesvaren V, Udayan R, et al. Cetirculating levels of inflammatory markers predict change in bone mineral density and resorption in older Adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93:1952-8. doi: 10.1210/jc.2007-2325</mixed-citation><mixed-citation xml:lang="en">Ding C, Paramesvaren V, Udayan R, et al. Cetirculating levels of inflammatory markers predict change in bone mineral density and resorption in older Adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93:1952-8. doi: 10.1210/jc.2007-2325</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gertz ER, Silverman NE, Wise KS, et al. Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J Clin Densitom. 2010 Jul-Sep;13(3):277-82. doi: 10.1016/j.jocd.2010.04.000</mixed-citation><mixed-citation xml:lang="en">Gertz ER, Silverman NE, Wise KS, et al. Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J Clin Densitom. 2010 Jul-Sep;13(3):277-82. doi: 10.1016/j.jocd.2010.04.000</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pasco JA, Kotowich MA, Henry MJ, et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006;296:2495-501. doi: 10.1001/jama.296.11.1353</mixed-citation><mixed-citation xml:lang="en">Pasco JA, Kotowich MA, Henry MJ, et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006;296:2495-501. doi: 10.1001/jama.296.11.1353</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cayley JA, Danielson ME, Boudreau RM, et al. Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study. J Bone Minerva Res. 2007;22:1088-95. doi: 10.1359/jbmr.070409</mixed-citation><mixed-citation xml:lang="en">Cayley JA, Danielson ME, Boudreau RM, et al. Inflammatory markers and incident fracture risk in older men and women: the health aging and body composition study. J Bone Minerva Res. 2007;22:1088-95. doi: 10.1359/jbmr.070409</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Meneses AM, Oliveira PD, Goncalves H, et al. Are cytocines (IL6, CRP and adiponectin) associated with bone mineral density in a young adult cohort? BMC Musculoskelet Disord. 2018;19:427-39. doi: 10.1186/s12891-1-018-2357-3</mixed-citation><mixed-citation xml:lang="en">Meneses AM, Oliveira PD, Goncalves H, et al. Are cytocines (IL6, CRP and adiponectin) associated with bone mineral density in a young adult cohort? BMC Musculoskelet Disord. 2018;19:427-39. doi: 10.1186/s12891-1-018-2357-3</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ilesanmi-Oyelere BL, Schollum L, Kuhn-Sherlok B, et al. Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing. 2019;16:15. doi: 10.1186/s12979-019-0155</mixed-citation><mixed-citation xml:lang="en">Ilesanmi-Oyelere BL, Schollum L, Kuhn-Sherlok B, et al. Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing. 2019;16:15. doi: 10.1186/s12979-019-0155</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-90. doi: 10.1161/01.atv.9.5.567</mixed-citation><mixed-citation xml:lang="en">Hansen GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-90. doi: 10.1161/01.atv.9.5.567</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Von der Thusen JH, Kuiper J, van Berrel TJC, et al. Interleukins in atherosclerosis: molecular pathways and therapeutic potential Pharmacol Rev. 2003;55(1):133-66. doi: 10.1124/pr.55.1.5</mixed-citation><mixed-citation xml:lang="en">Von der Thusen JH, Kuiper J, van Berrel TJC, et al. Interleukins in atherosclerosis: molecular pathways and therapeutic potential Pharmacol Rev. 2003;55(1):133-66. doi: 10.1124/pr.55.1.5</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness and incidence of ischemic stroke in the elderly. Circulation. 2003;108:166-70. doi: 10.1161/01.CIR.0000079160.07364.6A</mixed-citation><mixed-citation xml:lang="en">Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness and incidence of ischemic stroke in the elderly. Circulation. 2003;108:166-70. doi: 10.1161/01.CIR.0000079160.07364.6A</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317-22. doi: 10.1161/01.CIR.0000097109.90783.FC</mixed-citation><mixed-citation xml:lang="en">Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317-22. doi: 10.1161/01.CIR.0000097109.90783.FC</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
